BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15236781)

  • 1. Are phospholipid-binding antibodies implicated in the pathogenesis of diabetic microangiopathy?
    Giusti C
    Med Hypotheses; 2004; 63(2):235-8. PubMed ID: 15236781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in biochemical mechanisms of diabetic retinopathy.
    Giusti C; Gargiulo P
    Eur Rev Med Pharmacol Sci; 2007; 11(3):155-63. PubMed ID: 17970231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular complications of diabetes mellitus: what role for phospholipid-binding antibodies?
    Galtier-Dereure F; Biron C; Vies M; Bourgeois V; Schved JF; Bringer J
    Lupus; 1998; 7(7):469-74. PubMed ID: 9796849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune complexes and diabetic microangiopathy.
    Irvine WJ; Di Mario U; Guy K; Iavicoli M; Pozzilli P; Lumbroso B; Andreani D
    J Clin Lab Immunol; 1978 Nov; 1(3):187-91. PubMed ID: 756468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects.
    Camera A; Hopps E; Caimi G
    Minerva Endocrinol; 2007 Sep; 32(3):209-29. PubMed ID: 17912158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased glutathionylated hemoglobin (HbSSG) in type 2 diabetes subjects with microangiopathy.
    Sampathkumar R; Balasubramanyam M; Sudarslal S; Rema M; Mohan V; Balaram P
    Clin Biochem; 2005 Oct; 38(10):892-9. PubMed ID: 16051210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular complications in diabetes mellitus: the role of endothelial dysfunction.
    Schalkwijk CG; Stehouwer CD
    Clin Sci (Lond); 2005 Aug; 109(2):143-59. PubMed ID: 16033329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy.
    Singhania N; Puri D; Madhu SV; Sharma SB
    QJM; 2008 Jun; 101(6):449-55. PubMed ID: 18385148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endothelium and its morphofunctional changes in the pathogenesis of diabetic microangiopathy].
    Porta M; Molinatti P; La Selva M; Molinatti GM
    Minerva Med; 1988 Nov; 79(11):915-29. PubMed ID: 2462195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of anti-endothelial cell antibodies in the pathogenesis of atherosclerosis and diabetic angiopathy].
    Kluz J; Adamiec R
    Przegl Lek; 2003; 60(11):751-4. PubMed ID: 15058050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating diabetic retinopathy by tackling growth factor pathways.
    Chiarelli F; Giannini C; Di Marzio D; Mohn A
    Curr Opin Investig Drugs; 2005 Apr; 6(4):395-409. PubMed ID: 15898347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes.
    Zimmerman MA; Flores SC
    J Surg Res; 2009 Jul; 155(1):173-8. PubMed ID: 18805553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells.
    Makino N; Maeda T; Sugano M; Satoh S; Watanabe R; Abe N
    J Diabetes Complications; 2005; 19(6):347-55. PubMed ID: 16260352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening of subjects at high risk for diabetic microangiopathies].
    Grimaldi A; Davidoff P
    J Mal Vasc; 1989; 14(1):57-63. PubMed ID: 2646389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microvasculature in type 1 diabetes.
    Shore AC
    Semin Vasc Med; 2002 Feb; 2(1):9-20. PubMed ID: 16222592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies bind to activated but not resting endothelial cells: is an independent triggering event required to induce antiphospholipid antibody-mediated disease?
    Chen Q; Stone PR; Woon ST; Ching LM; Hung S; McCowan LM; Chamley LW
    Thromb Res; 2004; 114(2):101-11. PubMed ID: 15306152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma protein changes, blood viscosity, and diabetic microangiopathy.
    McMillan DE
    Diabetes; 1976; 25(2 SUPPL):858-64. PubMed ID: 971790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
    Peczyńska J; Urban M; Urban B; Głowińska B; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):41-8. PubMed ID: 15355738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of rheological factors on diabetic microangiopathies: is there an effective medical treatment for diabetic retinopathy?].
    Meunier I; Soubrane G; Coscas G
    Bull Soc Belge Ophtalmol; 1995; 256():67-70. PubMed ID: 8581233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.